Skip to content

Effect of thiamine tablet ( B 1) on general health and treatment success in infertile women with polycystic ovary syndrom

Effect of thiamine tablet ( B 1) on general health and treatment success in infertile women with polycystic ovary syndrom

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
IRCT
Registry ID
IRCT201510266917N3
Enrollment
64
Registered
2016-05-01
Start date
2015-12-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: polycystic ovarian syndrom. Condition 2: Female infertility.

Interventions

Intervention 1: Intervention group: treated with 300 mg vitamin B1 tablets product HAKIM Pharmaceutical Company once in the morning for a period of 4 weeks during experimental. Intervention 2: produ
Treatment - Drugs
Placebo
Intervention group: treated with 300 mg vitamin B1 tablets product HAKIM Pharmaceutical Company once in the morning for a period of 4 weeks during experimental
product Control group: treated with placebo tablets 300 mg product HAKIM Pharmaceutical Company during experimental

Sponsors

Vice chencelor for research, Iran Nursing and Midwifry School, Iran University of Medical Science
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
76 Years to 54 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: women with PCOs according to Rotterdam criteria; age 18-40 years be agree with study; not use alcohol; non usage psychological drugs; non addict or a history of addiction; without basic illness ; non usage of B1 last month; not using complimentary drug last month; at-last 3 period treatment of infertility exclusion criteria: not agree with continue the study; appears allergic symptoms; incorrect drug usage; discontinue treatment of infertility

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
General health. Timepoint: before and after of intervention. Method of measurement: standard questionarey.;Success treatment. Timepoint: before and after of intervention. Method of measurement: positive pregnancy test.

Secondary

MeasureTime frame
B-HCG. Timepoint: Before and after of experiment. Method of measurement: hormone assay.

Countries

Iran (Islamic Republic of)

Contacts

Public Contactmahtab moti

Iran Nursing and Midwifry School

mahtab_moti@gmail.com+98 21 8820 8159

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 7, 2026